Literature DB >> 15142474

The interface of psychiatry and irritable bowel syndrome.

David G Folks1.   

Abstract

The interface of psychiatry and irritable bowel syndrome (IBS) is well established, with psychiatric comorbidity approaching 20% to 60%. Anxiety disorders, depressive disorders, and somatoform disorders are the more frequently occurring comorbid conditions. Moreover, psychosocial stressors and history of trauma and abuse play a significant role in the onset and perpetuation of IBS symptoms. The psychiatric management of IBS more effectively uses a collaborative approach between a mental health practitioner and a primary care clinician or gastroenterologist. Psychiatric treatment includes the use of pharmacotherapy with antidepressants or anxiolytics, psychotherapy, and attention to psychosocial stressors. Psychiatric interventions have consistently demonstrated effectiveness in reducing IBS symptoms and improvement of patient functioning.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15142474     DOI: 10.1007/s11920-004-0066-0

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  54 in total

1.  Irritable bowel syndrome and mirtazapine.

Authors:  S G Thomas
Journal:  Am J Psychiatry       Date:  2000-08       Impact factor: 18.112

2.  Clinical characteristics of women with a history of childhood abuse: unhealed wounds.

Authors:  J McCauley; D E Kern; K Kolodner; L Dill; A F Schroeder; H K DeChant; J Ryden; L R Derogatis; E B Bass
Journal:  JAMA       Date:  1997-05-07       Impact factor: 56.272

3.  Patient knowledge and educational needs in irritable bowel syndrome.

Authors:  M A O'Sullivan; N Mahmud; D P Kelleher; E Lovett; C A O'Morain
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-01       Impact factor: 2.566

Review 4.  The role of psychological factors in gastrointestinal conditions. A review pertinent to DSM-IV.

Authors:  D G Folks; F C Kinney
Journal:  Psychosomatics       Date:  1992       Impact factor: 2.386

5.  The treatment of irritable bowel syndrome with hypnotherapy.

Authors:  T E Galovski; E B Blanchard
Journal:  Appl Psychophysiol Biofeedback       Date:  1998-12

Review 6.  Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials.

Authors:  R B Lydiard; S A Falsetti
Journal:  Am J Med       Date:  1999-11-08       Impact factor: 4.965

7.  Frequency of "functional" gastrointestinal disorders.

Authors:  A Ferguson; W Sircus; M A Eastwood
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

8.  Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders.

Authors:  E A Guthrie; F H Creed; P J Whorwell; B Tomenson
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

Review 9.  Diagnosis of irritable bowel syndrome.

Authors:  Kevin W Olden
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

10.  Symptom relief with amitriptyline in the irritable bowel syndrome.

Authors:  M Rajagopalan; G Kurian; J John
Journal:  J Gastroenterol Hepatol       Date:  1998-07       Impact factor: 4.029

View more
  30 in total

Review 1.  Corticotropin-releasing factor receptors and stress-related alterations of gut motor function.

Authors:  Yvette Taché; Bruno Bonaz
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 2.  The microbiome: stress, health and disease.

Authors:  Rachel D Moloney; Lieve Desbonnet; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Mamm Genome       Date:  2013-11-27       Impact factor: 2.957

3.  Rare Variants of the Serotonin Transporter Are Associated With Psychiatric Comorbidity in Irritable Bowel Syndrome.

Authors:  Ruth Kohen; Julia H Tracy; Eric Haugen; Kevin C Cain; Monica E Jarrett; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2016-02-24       Impact factor: 2.522

Review 4.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

5.  Pharmacological restoration of gut barrier function in stressed neonates partially reverses long-term alterations associated with maternal separation.

Authors:  Marion Rincel; Maïwenn Olier; Amandine Minni; Camille Monchaux de Oliveira; Yann Matime; Eric Gaultier; Isabelle Grit; Jean-Christophe Helbling; Anna Maria Costa; Amandine Lépinay; Marie-Pierre Moisan; Sophie Layé; Laurent Ferrier; Patricia Parnet; Vassilia Theodorou; Muriel Darnaudéry
Journal:  Psychopharmacology (Berl)       Date:  2019-05-23       Impact factor: 4.530

Review 6.  Irritable bowel syndrome: a microbiome-gut-brain axis disorder?

Authors:  Paul J Kennedy; John F Cryan; Timothy G Dinan; Gerard Clarke
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

7.  Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns.

Authors:  Elisa Martín-Merino; Ana Ruigómez; Saga Johansson; Mari-Ann Wallander; Luis A García-Rodriguez
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

8.  Development and validation of new disease-specific measures of somatization and comorbidity in IBS.

Authors:  Elizabeth W MacLean; Olafur S Palsson; Marsha J Turner; William E Whitehead
Journal:  J Psychosom Res       Date:  2012-08-31       Impact factor: 3.006

Review 9.  Central Network Dynamics Regulating Visceral and Humoral Functions.

Authors:  Rita J Valentino; Patrice Guyenet; Xun Helen Hou; Melissa Herman
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

Review 10.  Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.

Authors:  Maria M Buckley; Siobhain M O'Mahony; Dervla O'Malley
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.